ASA issues ruling against misleading hyperbaric oxygen therapy promo
The Advertising Standards Authority (ASA) has upheld a claim against a provider of hyperbaric oxygen therapy after its website made misleading claims about the treatment.
The Advertising Standards Authority (ASA) has upheld a claim against a provider of hyperbaric oxygen therapy after its website made misleading claims about the treatment.
Dr Ahmed El Houssieny discusses the evidence for hyperbaric oxygen therapy in the management of vascular compromise and when the treatment may be used in practice
Subscriber content
To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.
Already a subscriber? Log in